Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet

Journal of Hepatology

Volumn 49, Issue 6, 2008, Pages 1019-1028

  Ahn, Jiyun ^a   Cho, Iljin ^a   Kim, Suna ^a   Kwon, Daeyoung ^a   Ha, Taeyoul ^a  

^a Korea Food Research Institute   (South Korea)

Author keywords

Atherogenic diet; Lipid metabolism; Microarray analysis; Non alcoholic steatohepatitis; Resveratrol

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RESVERATROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; DYSLIPIDEMIA; FATTY LIVER; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REPRESSION; GENOME ANALYSIS; HEPATOMEGALY; HISTOLOGY; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; LIVER; LIVER PROTECTION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WEIGHT GAIN; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; DIET, ATHEROGENIC; EATING; FATTY LIVER; GENE EXPRESSION; LIPID METABOLISM; LIPIDS; LIVER; MALE; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SIZE; STILBENES;

EID: 55549097087     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.08.012     Document Type: Article

References (41)

1. Clark J.M., Brancati F.L., and Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98 (2003) 960-967
2. Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37 (2003) 917-923
3. Renaud S., and de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339 (1992) 1523-1526
4. Artaud-Wild S.M., Connor S.L., Sexton G., and Connor W.E. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation 88 (1993) 2771-2779
5. Chen R.S., Wu P.L., and Chiou R.Y. Peanut roots as a source of resveratrol. J Agric Food Chem 50 (2002) 1665-1667
6. Mukamal K.J., Conigrave K.M., Mittleman M.A., Camargo Jr. C.A., Stampfer M.J., Willett W.C., et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 348 (2003) 109-118
7. Manna S.K., Mukhopadhyay A., and Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164 (2000) 6509-6519
8. Olas B., and Wachowicz B. Resveratrol and vitamin C as antioxidants in blood platelets. Thromb Res 106 (2002) 143-148
9. Liu J.C., Chen J.J., Chan P., Cheng C.F., and Cheng T.H. Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension 42 (2003) 1198-1205
10. Sato M., Maulik N., and Das D.K. Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants. Ann NY Acad Sci 957 (2002) 122-135
11. Briaud I., Harmon J.S., Kelpe C.L., Segu V.B., and Poitout V. Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes 50 (2001) 315-321
12. Yu J., Ip E., Dela Pena A., Hou J.Y., Sesha J., Pera N., et al. COX-2 induction in mice with experimental nutritional steatohepatitis: role as pro-inflammatory mediator. Hepatology 43 (2006) 826-836
13. Peng X., Wood C.L., Blalock E.M., Chen K.C., Landfield P.W., and Stromberg A.J. Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics 4 (2003) 26
14. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
15. Bleicher K.B., Pippert T.R., Glaab W.E., Skopek T.R., Sina J.F., and Umbenhauer D.R. Use of real-time gene-specific polymerase chain reaction to measure RNA expression of three family members of rat cytochrome P450 4A. J Biochem Mol Toxicol 15 (2001) 133-142
16. Bellentani S., Saccoccio G., Masutti F., Croce L.S., Brandi G., Sasso F., et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Int Med 132 (2000) 112-117
17. Bellentani S., and Tiribelli C. The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol 35 (2001) 531-537
18. Shen L., Fan J.G., Shao Y., Zeng M.D., Wang J.R., Luo G.H., et al. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol 9 (2003) 1106-1110
19. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
20. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
21. Zimmet P., Magliano D., Matsuzawa Y., Alberti G., and Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 12 (2005) 295-300
22. Bugianesi E., Gentilcore E., Manini R., Natale S., Vanni E., Villanova N., et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 100 (2005) 1082-1090
23. Del Gaudio A., Boschi L., Del Gaudio G.A., Mastrangelo L., and Munari D. Liver damage in obese patients. Obes Surg 12 (2002) 802-804
24. Clark J.M. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 40 (2006) S5-S10
25. Dixon J.B., Bhathal P.S., and O'Brien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121 (2001) 91-100
26. Ratziu V., Giral P., Charlotte F., Bruckert E., Thibault V., Theodorou I., et al. Liver fibrosis in overweight patients. Gastroenterology 118 (2000) 1117-1123
27. Matsuzawa N., Takamura T., Kurita S., Misu H., Ota T., Ando H., et al. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46 (2007) 1392-1403
28. Fremont L. Biological effects of resveratrol. Life Sci 66 (2000) 663-673
29. Wolter F., Ulrich S., and Stein J. Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in colorectal cancer: key role of polyamines?. J Nutr 134 (2004) 3219-3222
30. Cai Y.J., Fang J.G., Ma L.P., Yang L., and Liu Z.L. Inhibition of free radical-induced peroxidation of rat liver microsomes by resveratrol and its analogues. Biochim Biophys Acta 1637 (2003) 31-38
31. Kasdallah-Grissa A., Mornagui B., Aouani E., Hammami M., Gharbi N., Kamoun A., et al. Protective effect of resveratrol on ethanol-induced lipid peroxidation in rats. Alcohol Alcohol 41 (2006) 236-239
32. Kasdallah-Grissa A., Mornagui B., Aouani E., Hammami M., El May M., Gharbi N., et al. Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sci 80 (2007) 1033-1039
33. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196
34. Pfluger P.T., Herranz D., Velasco-Miguel S., Serrano M., and Tschop M.H. Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci USA 105 (2008) 9793-9798
35. Schechter I., Conrad D.G., Hart I., Berger R.C., McKenzie T.L., Bleskan J., et al. Localization of the squalene synthase gene (FDFT1) to human chromosome 8p22-p23.1. Genomics 20 (1994) 116-118
36. Smith S. The animal fatty acid synthase: one gene, one polypeptide, seven enzymes. FASEB J 8 (1994) 1248-1259
37. Maier T., Jenni S., and Ban N. Architecture of mammalian fatty acid synthase at 4.5 Å resolution. Science 311 (2006) 1258-1262
38. Wilson-Fritch L., Burkart A., Bell G., Mendelson K., Leszyk J., Nicoloro S., et al. Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol 23 (2003) 1085-1094
39. Benach J., Winberg J.O., Svendsen J.S., Atrian S., Gonzalez-Duarte R., and Ladenstein R. Drosophila alcohol dehydrogenase: acetate-enzyme interactions and novel insights into the effects of electrostatics on catalysis. J Mol Biol 345 (2005) 579-598
40. Deeb S.S., Nevin D.N., Iwasaki L., and Brunzell J.D. Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity. Hum Mutat 8 (1996) 319-325
41. Endemann G., Stanton L.W., Madden K.S., Bryant C.M., White R.T., and Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268 (1993) 11811-11816